← Back to Search

Dietary Supplement

Keto5 XOGenius Beverage for Cardiovascular Disease

N/A

Recruiting

Led By Robert M Brothers, PhD

Research Sponsored by The University of Texas at Arlington

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline, 2 weeks post daily consumption of keto5 xogenius, & 4 weeks of daily keto5 xogenius consumption

Awards & highlights

Study Summary

"This trial aims to study the impact of drinking more Keto5 XOGenius beverage each day on health factors related to brain and body conditions. It will also look into how drinking this beverage daily affects waist

Who is the study for?

This trial is for individuals who may be at risk for heart disease, cognitive issues, or high blood pressure. Participants should be interested in healthy eating and looking to improve their waist size, weight, and BMI.Check my eligibility

What is being tested?

The study is testing the effects of a beverage called Keto5 XOGenius on health markers related to cardiovascular and neurocognitive conditions. It will measure changes in waist circumference, body weight, and BMI with daily consumption.See study design

What are the potential side effects?

The description provided does not specify side effects; however, as with any dietary supplement or change in diet, potential side effects could include digestive discomfort or allergic reactions.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline, 2 weeks post daily consumption of keto5 xogenius, & 4 weeks of daily keto5 xogenius consumption

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline, 2 weeks post daily consumption of keto5 xogenius, & 4 weeks of daily keto5 xogenius consumption

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 2 weeks post daily consumption of keto5 xogenius, & 4 weeks of daily keto5 xogenius consumption for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Arterial stiffness

Endothelial Function

Lipid profile (Total-C, LDL-C, VLDL-C, HDL-C, TG)

+2 more

Trial Design

1Treatment groups

Experimental Treatment

Group I: Keto5 XOGenius BeverageExperimental Treatment1 Intervention

Keto5 XOGenius Beverage contains natural ingredients that are high in the Ketone β-OHB content and has anti-inflammatory and antioxidant properties

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

The University of Texas at ArlingtonLead Sponsor

43 Previous Clinical Trials

4,898 Total Patients Enrolled

Robert M Brothers, PhDPrincipal InvestigatorUniversity of Texas at Arlington

5 Previous Clinical Trials

199 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Do I meet the necessary criteria to participate in this research trial?

"Individuals aged between 18 and 50 with a history of cardiovascular illness are eligible for participation in this research. The trial aims to enroll a total of 40 participants."

Answered by AI

Is the research study open to individuals younger than 40 years old?

"Individuals aged over 18 and under 50 are eligible for enrollment in this study."

Answered by AI

How many individuals are participating in the entirety of this research study?

"Indeed, the details on clinicaltrials.gov affirm that this ongoing trial is actively seeking participants. Initially shared on August 1st, 2023, it was last revised on March 12th, 2024. The study aims to recruit 40 patients from a single site."

Answered by AI

Are new patients currently being accepted for enrollment in this medical study?

"Yes, information provided on clinicaltrials.gov confirms the ongoing patient recruitment for this specific trial. The trial was initially listed on August 1st, 2023 and has been most recently revised on March 12th, 2024. A total of 40 individuals are being sought from a single research site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health

Matthew Brothers 2023. "The Impact of KETO5 XOGenius Beverage on Markers of Physiological and Neurocognitive Health". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06318390.

All > Dallas > Fort Worth